Jeff Yass’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-138,460
| Closed | -$709K | – | 13709 |
|
|
2025
Q2 | $528K | Buy |
138,460
+64,551
| +87% | +$200K | ﹤0.01% | 9053 |
|
|
2025
Q1 | $194K | Buy |
73,909
+52,643
| +248% | +$171K | ﹤0.01% | 10960 |
|
|
2024
Q4 | $75.3K | Buy |
21,266
+2,500
| +13% | +$9.58K | ﹤0.01% | 11502 |
|
|
2024
Q3 | $85.6K | Sell |
18,766
-5,169
| -22% | -$25K | ﹤0.01% | 11144 |
|
|
2024
Q2 | $104K | Sell |
23,935
-2,953
| -11% | -$13K | ﹤0.01% | 11005 |
|
|
2024
Q1 | $135K | Sell |
26,888
-37,829
| -58% | -$212K | ﹤0.01% | 10993 |
|
|
2023
Q4 | $406K | Buy |
64,717
+40,226
| +164% | +$230K | ﹤0.01% | 9152 |
|
|
2023
Q3 | $174K | Sell |
24,491
-61,164
| -71% | -$482K | ﹤0.01% | 10381 |
|
|
2023
Q2 | $873K | Sell |
85,655
-140,998
| -62% | -$1.47M | ﹤0.01% | 7015 |
|
|
2023
Q1 | $2.06M | Buy |
226,653
+135,446
| +149% | +$992K | ﹤0.01% | 5071 |
|
|
2022
Q4 | $654K | Buy |
91,207
+28,049
| +44% | +$171K | ﹤0.01% | 7183 |
|
|
2022
Q3 | $412K | Sell |
63,158
-9,465
| -13% | -$50.6K | ﹤0.01% | 8988 |
|
|
2022
Q2 | $350K | Buy |
72,623
+31,934
| +78% | +$158K | ﹤0.01% | 9155 |
|
|
2022
Q1 | $231K | Buy |
+40,689
| New | +$200K | ﹤0.01% | 10896 |
|
|
2020
Q2 | – | Sell |
-11,759
| Closed | -$87K | – | 10828 |
|
|
2020
Q1 | $87K | Buy |
+11,759
| New | +$85.3K | ﹤0.01% | 9402 |
|
|
2019
Q1 | – | Sell |
-17,711
| Closed | -$67K | – | 9724 |
|
|
2018
Q4 | $67K | Buy |
+17,711
| New | +$83.2K | ﹤0.01% | 8380 |
|
Jeff Yass's SCPH Position: Q3 2025 in Review
Jeff Yass sold out of scPharmaceuticals (SCPH) in Q3 2025, closing a stake of 138,460 shares — an estimated $709K sold.
Jeff Yass first reported a position in SCPH in Q4 2018 and held it in 16 quarters. The position peaked at $2.06M in Q1 2023. 110 funds tracked by Wall St. Rank hold SCPH as of Q3 2025.
- Jeff Yass reported no remaining scPharmaceuticals position as of Q3 2025 after selling out during the quarter.
- Jeff Yass sold 138,460 scPharmaceuticals shares in Q3 2025, an estimated $709K.
- Jeff Yass first reported a position in scPharmaceuticals in Q4 2018 and held it in 16 quarters.
- Jeff Yass's scPharmaceuticals position peaked at $2.06M in Q1 2023.
- 110 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2025.
Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.